拮抗促纤维化microRNA-21改善小鼠慢性肾移植功能障碍
该研究在小鼠同种异体肾移植模型中,通过全miRNA组表达分析发现纤维化相关miR-21a-5p显著上调,并揭示其经IL-6/STAT3转录激活及巨噬细胞囊泡传递促进肾纤维化。治疗性沉默miR-21a-5p可减轻纤维化、炎症浸润、组织损伤及BANFF评分,并改善肾功能。
要点
- miR-21a-5p在同种异体肾移植后慢性功能障碍模型中显著上调
- 巨噬细胞来源囊泡可将miR-21a-5p传递至肾成纤维细胞促纤维化
- 沉默miR-21a-5p可减轻小鼠慢性移植肾功能障碍
核心结论
- 沉默miR-21a-5p可能成为肾移植后阻止慢性移植肾功能障碍进展的治疗选择。
研究设计与样本
- 采用小鼠同种异体肾移植模型,于肾移植后6周出现慢性移植肾功能障碍。
主要发现
- 全miRNA组表达分析显示纤维化相关miR-21a-5p为高度上调的miRNA之一。
- 肾成纤维细胞中miR-21a-5p由IL-6诱导的STAT3转录激活。
- LPS激活的巨噬细胞与肾成纤维细胞共培养增加miR-21a-5p及纤维化和炎症标志物表达。
- 巨噬细胞通过小囊泡分泌成熟miR-21a-5p并被肾成纤维细胞内化,促进促纤维化和促炎效应。
- Notch2受体被鉴定为miR-21a-5p潜在靶点并经荧光素酶报告基因试验验证。
关键数值与推荐
- 小鼠同种异体肾移植后治疗性沉默miR-21a-5p,纤维化发展、炎症细胞浸润、组织损伤及BANFF病变评分均减轻。
- 在生命支持模型中,拮抗miR-21a-5p对肾功能有有益效应。
临床怎么用
- miR-21a-5p沉默可能作为肾移植后患者阻止慢性移植肾功能障碍发展的治疗选项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic renal allograft dysfunction (CAD) is a major limiting factor of long-term graft survival. It is characterized by interstitial fibrosis and tubular atrophy. The underlying pathomechanisms are incompletely understood. MicroRNAs are powerful regulators of gene expression and may have an impact on various diseases by direct mRNA decay or translational inhibition. A murine model of allogenic kidney transplantation was used resulting in CAD at 6 weeks after kidney transplantation. We identified fibrosis-associated miR-21a-5p by whole miRNAome expression analysis to be among the most highly upregulated miRNAs. In vitro in renal fibroblasts, miR-21a-5p was transcriptionally activated by interleukin 6-induced signal transducer and activator of transcription 3. Co-culture of LPS-activated macrophages with renal fibroblasts increased expression levels of miR-21a-5p and markers of fibrosis and inflammation. In addition, mature miR-21a-5p was secreted by macrophages in small vesicles, which were internalized by renal fibroblasts, thereby promoting profibrotic and proinflammatory effects. Notch2 receptor was identified as a potential target of miR-21a-5p and validated by luciferase gene reporter assays. Therapeutic silencing of miR-21a-5p in mice after allogenic kidney transplantation resulted in an amelioration of CAD, as indicated by a reduction in fibrosis development, inflammatory cell influx, tissue injury and BANFF lesion scoring. In a life-supporting model, miR-21a-5p antagonism had beneficial effects on kidney function. miR-21a-5p silencing may therefore be a viable therapeutic option in the treatment of patients following kidney transplantation to halt the development of CAD.
引用
- Schauerte C, Hübner A, Rong S, et al. Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction. Kidney Int. 2017. PMID: 28396121. doi:10.1016/j.kint.2017.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。